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Abstract
Acute upper and lower gastrointestinal bleeding, enteral 
feeding, cecostomy tubes and luminal strictures are some 
of the common reasons for gastroenterology service. 
While surgery was initially considered the main treatment 
modality, the advent of both therapeutic endoscopy and 
interventional radiology have resulted in the paradigm 
shift in the management of these conditions. In this 
paper, we discuss the patient’s work up, indications, and 
complementary roles of endoscopic and angiographic 
management in the settings of gastrointestinal bleeding, 
enteral feeding, cecostomy tube placement and luminal 
strictures. These conditions often require multidisciplinary 
approaches involving a team of interventional radio-
logists, gastroenterologists and surgeons. Further, the 
authors also aim to describe how the fields of inter-
ventional radiology and gastrointestinal endoscopy are 
overlapping and complementary in the management of 
these complex conditions.
Key words: Gastrointestinal hemorrhage; Enteral 
nutrition; Interventional radiology; Gastroenterology; 
Endoscopy 
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Core tip: This paper reviews the current information and 
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in the management of various luminal gastrointestinal 
conditions such as gastrointestinal bleeding, enteral 
feeding, placement of cecostomy tubes and strictures. 
We discuss the multidisciplinary approach, indications, 
contraindications and management of these conditions in 
an attempt to provide an educational experience for all 
your esteemed readers.
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INTRODUCTION
Various gastrointestinal (GI) diseases such as acute GI 
bleeding, esophageal strictures, strictures associated with 
inflammatory bowel disease and enteral feedings were 
traditionally managed by the surgeons alone. However, 
surgery has been associated with high morbidity and 
mortality rates, thus leading on to a search for other 
modalities that were less invasive and equally or better 
efficacious. Though the first endoluminal visualization of 
the stomach was performed by Kussmaul in 1868, it was 
not until 1958 that the first fiberscope was introduced by 
Hirschowitz et al[1]. From then, the field of endoscopy has 
evolved rapidly with various innovations such as charged 
couple devices, video chip to hemostatic clips, biopsy 
forceps, snares, banding kit, etc. These innovations 
have expanded the horizons of endoscopy, changing 
it from a mere diagnostic tool to one of therapeutics. 
Endoscopists are now able to treat GI bleeding, perform 
biopsies, remove polyps, dilate strictures, place stents 
and feeding tubes. Similar to gastroenterology, the field 
of interventional radiology (IR) has had its share of 
technological advances. Fluoroscopy advanced during 
the early 1900s. The first angioplasty by Dotter in 1964 
was a landmark in vascular interventions[2]. Embolization, 
angioplasty, and other fluoroscopic guided techniques 
significantly advanced have also decreased the need for 
first line surgery in many patients[2,3].
Interventional endoscopy and radiology are two 
minimally invasive disciplines that overlap and com­
plement one another in the care of multiple complex 
GI disease processes. Acute GI bleeding is a common 
presentation to the emergency room which can be life 
threatening. Management of this often times requires a 
collaboration between a gastroenterologist, radiologist, 
and a surgeon. However, with the advent of therapeutic 
endoscopy and interventional radiology, in many cases, 
the role of surgery is now limited to technically challenging 
cases not amenable to endoscopic or radiological inter­
vention. Though few articles addressing the need for 
multidisciplinary approach in treating GI bleeding have 
been published, there is a paucity of literature for other 
above mentioned conditions. Thus, in this article we 
hope to not only outline the role of endoscopists and 
radiologists in managing various GI conditions but also 
their complementary roles to overcome their individual 
short comings. Since this is an expansive topic we will 
be only focusing on endoluminal conditions such as GI 
bleeding, access for enteral nutrition, cecostomy tube 
placement and strictures. Hepatobiliary pathology including 
variceal bleeding, portal hypertensive gastropathy, biliary 
drainage, endoscopic ultrasound (EUS) guided internal 
drainage, EUS guided celiac block and tissue biopsy will 
be described elsewhere.
lITeRaTURe ReSeaRCH
We conducted an English literature review of the various 
GI topics. Searches were performed for GI hemorrhage 
with respect to management, endoscopy and inter­
ventional radiology. Searches for hemorrhage were further 
subdivided into upper and lower GI bleeding. Similar 
review was performed for enteral feeding, cecostomy 
tubes, and stricture management. Further literature was 
reviewed by evaluating references. Also, since many 
patients are complex and require the opinion of several 
specialists in the outpatient and emergent setting, 
the authors added the opinion of our institution when 
appropriate.
Acute upper GI bleed
Acute life threatening GI bleeding once considered a 
surgical emergency with significant mortality continues to 
have a high mortality rate despite tremendous advances 
made in endoscopic and radiographic techniques. The 
incidence of GI bleeding tends to increase with age and 
ranges between 37 and 172/100000 adults[4,5]. It has 
been reported to account for approximately 350000 
hospital admissions per year in the United States alone[6]. 
Rebleeding following interventions remains relatively 
high at reported rates of 7%­16%[4]. It is a frequent 
presenting symptom to the hospital and requires mana­
gement by a multidisciplinary team comprising of gastro­
enterologists, surgeons, interventional radiologists, and 
anesthesiologists[7]. 
GI bleeding is usually arbitrarily divided between upper 
and lower bleeds. Upper GI bleed constitutes any bleed 
that originates in the GI tract proximal to ligament of Treitz 
while anything distal constitutes a lower GI bleed. Upper 
GI hemorrhage may manifest as hematemesis, coffee 
ground emesis, bloody return through nasogastric tube 
or feeding tube, melena or as brisk hematochezia with 
hemodynamic compromise. Lower GI bleeding usually 
presents as melena (if from the right colon or distal small 
bowel) or hematochezia. The most common cause of 
nonvariceal upper GI bleed is peptic ulcer disease[8]. Other 
etiologies include neoplasms, inflammation, iatrogenic, 
trauma, ischemia, and vascular malformations (such as 
Dieulafoy’s lesions and angioectasis) with more than one 
diagnosis noted in 16%­20% of cases[4]. 
When a patient presents to the emergency room with 
99 March 28, 2017|Volume 9|Issue 3|WJR|www.wjgnet.com
GI bleeding, initial assessment must be made to ensure 
hemodynamic stability of the patient and determine 
the need for urgent intervention. Resuscitation with 
crystalloids and blood transfusion must be performed. 
In patients suspected with nonvariceal upper GI bleed, 
proton pump inhibitors must be initiated as they reduce 
the chances of finding high risk stigmata during endo­
scopy[9]. If the patient is stable enough to undergo 
upper endoscopy, then it must be performed next as it 
can be both diagnostic and therapeutic. The patient is 
placed in a left lateral position with head bend forward to 
facilitate the insertion of the endoscope. At the time of 
upper endoscopy, there are various endoscopic treatment 
modalities available to help achieve hemostasis. Traditionally, 
endoscopic therapy has been broadly categorized into 
injection, thermal and mechanical methods. 
Injection therapy
Injection therapy includes administration of epinephrine 
(1:10000) around the bleeding vessel. This was first 
described by Soehendra et al[10]. In 1988, Chung et al[11] 
presented the first randomized trial comparing injection 
therapy to medical therapy in 68 patients and reported 
reduced surgery, transfusion requirements and shorter 
hospital stay in the group with injection therapy. This is 
performed by placing multiple aliquots of 0.5 to 1 mL of 
diluted epinephrine (1:10000) 1 to 2 mm away from the 
bleeding vessel. This technique works by a combination 
of tamponade and transient vasoconstriction. Typically, 
5 mL can be administered in one setting but on occasion 
as high as 25 mL have also been administered with 
no significant side effects except transient tachycardia. 
However, it should be avoided in patients with active 
ongoing cardiac ischemia. After injection of epinephrine 
blanching of the surrounding mucosa is noticed. Studies[12,13] 
have demonstrated that epinephrine alone is effective, 
but epinephrine in combination with another endoscopic 
modality is superior to epinephrine alone. This is most 
likely due to its transient duration of action. 
More recently hemostatic powders have gained 
popularity. These are designed to be delivered via a 
catheter passed through the accessory channel of the 
endoscope. Hemospray is an inorganic powder that is 
metabolically inert and nontoxic. This acts in two ways; 
the first is upon coming in contact with water it forms 
a stable mechanical barrier over the vessel and stops 
the bleeding. Secondly, it acts by increasing the local 
concentration of clotting factors and promoting clot 
formation[14]. The adherent clot that it forms sloughs off 
within 24-72 h and is eliminated from the GI tract[15]. 
In 2011, Sung et al[15] conducted a pilot study in 20 pa­
tients with active peptic ulcer bleeding. Hemostasis was 
achieved in all but one patient (95%). It has also proven 
to be efficacious in tumor related bleeding[16] given its ease 
of application to large surfaces even in difficult positions. In 
a small study, Holster et al[17] evaluated the efficacy of this 
novel technique in patients on antithrombotic agents and 
concluded that endoscopic hemostasis by Hemospray is 
not decreased by systemic antithrombotic effects such 
as Plavix, aspirin, or vitamin K antagonists. Thus, though 
initial reports are fascinating, further trials with larger 
populations are needed.
THeRMal MeTHODS
Thermal devices can be divided into contact devices 
such as heater probe and bipolar probe and noncontact 
devices such as argon plasma coagulation (APC). Contact 
probes are ideal for bleeding vessels that are less than 2 
to 3 mm in size. The goal of a contact probe is to apply 
firm pressure on the visible vessel to interrupt the blood 
flow and then to apply enough heat to weld the walls of 
the vessel together[18]. Heater probes contain a nonstick 
Teflon coated heating element directly delivering heat to 
the vessel. It also contains three irrigation ports on the 
sides to wash out the clots and allow better visualization 
of the vessel. The heat is then delivered for a preset 
amount of time by tapping the coagulation pedal. For 
the treatment of actively bleeding ulcer four pulses of 30 
Joules must be applied[18].
Bipolar probes work by delivering electrical current 
from an electrosurgical generator to electrodes situated 
at the tip of the probe. Tissue coagulation is obtained 
indirectly by conversion of electrical energy to heat 
energy. Similar to heater probes they also contain a 
water channel which is, however, centrally located. Unlike 
the heater probe coagulation time is determined by the 
amount of time the endoscopist presses the coagulation 
foot pedal. For bleeding peptic ulcers, a setting of 20 
watts for a contact period of 7 to 10 s is suggested[19]. 
APC is a non­contact monopolar thermal method which 
acts by delivering high frequency electrical current 
conducted via argon gas (that has been ionized) to 
the tissue. This method, however, produces superficial 
coagulation only, and once the tissue gets desiccated, 
it loses its electrical conductivity. Hence, the maximum 
depth is about 3 mm to 4 mm which is a safety feature 
to prevent deep tissue injury. The probe can be circu-
mferential, end or side fearing, and should be held 
1­2 mm away from the target. However, owing to its 
superficial effect it is not routinely used for peptic ulcer 
disease. 
MeCHaNICal MeTHODS
Mechanical hemostasis can be achieved by causing a 
physical tamponade of the bleeding site. Currently two 
types of instruments are widely used: Clips and banding 
kits. The use of through-the-scope clips was first reported 
in 1975 by Hayashi et al[20] for endoscopic hemostasis. 
Since then, tremendous improvements have been made 
in both the clip designs and their deployment devices. 
They are either single use clips or reusable clips which 
can be rotated, closed and reopened multiple times. 
They are deployed over the bleeding vessel and act by 
clamping the bleeding point. They slough off within few 
days to weeks. They are most beneficial for accessible 
lesions that do not have a hard fibrotic base. Based on 
Ray DM et al . Complementary roles of IR and GI
100 March 28, 2017|Volume 9|Issue 3|WJR|www.wjgnet.com
historical data, the vessel should be ≤ 2 mm in size. 
Recently, over­the­scope clipping devices have become 
available and can be applied to larger vessels. Banding 
devices are mostly used for esophageal varices, which 
will not be discussed in this review.
Etiologies
The two most common etiologies for peptic ulcers include 
non­steroidal anti­inflammatory drugs and helicobacter 
pylori infection. These are easily visualized at the time 
of endoscopy, and certain endoscopic features such as 
active bleeding, spurting arterial vessel, adherent clot 
and non­bleeding visible vessel, predict high rate of 
rebleeding and hence require endoscopic therapy and/or 
interventional embolization therapy[21]. While treating a high 
risk stigmata ulcer, it is recommended that injection therapy 
should not be used alone as studies[12,13] demonstrated 
that the combination therapy of epinephrine with clips 
or thermal devices was superior to injection alone. APC 
have not been demonstrated to be useful in peptic ulcer 
bleeding. Through-the-scope Hemoclips and contact 
thermal devices have found to be equally efficacious in 
treating vessels less than 2 mm in size[22]. Placing a clip 
may be challenging in difficult to access locations such 
as the posterior wall of the duodenal bulb where contact 
thermocoagulation should be attempted. In cases with 
oozing without a visible vessel monotherapy is adequate. 
Treating ulcers with adherent clots is challenging as 
meta­analysis[22] has shown conflicting results regarding 
endoscopic treatment vs medical management. 
Dieulafoy’s lesions which are characterized by a large 
submucosal vessel eroding through the mucosa and then 
rupturing were first described almost a hundred years 
ago. Endoscopically it is identified when there is visible 
or an active bleeding vessel with no ulcer. Treatment is 
usually similar to actively bleeding vessel in peptic ulcer 
disease and includes injection therapy, clips, banding 
devices, heater probe and bipolar probe. Studies have 
shown that monotherapy with injection should not be 
attempted. Bipolar probes should be set at 20 watts and 
applied for 10 to 12 s, and heater probes should be set 
at 30 joules and 4 pulse should be administered.
Mallory Weiss tears are usually self­limited bleeds 
and do not need endoscopic therapy. However, in the 
presence of ongoing active bleeding clips are preferred, 
though other devices such as band devices and 
electrocautery have also been reported[23,24]. The settings 
for bipolar and heater probes include 15-20 watts for 4 
s and 15­20 joules for 3 pulses respectively. However, 
there are no trials comparing the various treatment 
modalities. 
Angioectasias and gastric antral vascular ectasias 
(GAVE) usually cause chronic and obscure GI bleeding. 
These are usually treated with APC. The probe should be 
set at 45 watts with 1 L/min argon flow rate for vascular 
ectasia; whereas for GAVE, 60 watts with 1 L/min is 
applied for deeper tissue penetration. Though other 
previously mentioned methods have been used, there 
are again no prospective comparison trials. 
However, despite the advances made in therapeutic 
endoscopies there are still certain instances where we 
fail to achieve hemostasis endoscopically. Thus, it is 
important to realize the limitations of various modalities 
and be aware of other options that we may have. Large 
bleeding vessels more than 2 mm to 3 mm in size, or 
high stigmata ulcer in posterior wall of the duodenal bulb 
may not be amenable to endoscopic intervention. Rarely 
interventions in such instances may fuel a massive GI 
bleed requiring IR intervention (Figures 1­3).
Pre-intervention imaging
If a patient is stable enough during presentation and 
plans are not made for immediate endoscopy, pre­
procedure imaging can be performed to attempt localization 
of the culprit vessel or other underlying etiologies. Com­
puterized tomography (CT) scanning is readily available 
in many centers and can tolerate patients with a tenuous 
clinical picture due to the speed of image acquisition. 
Multiphasic CT is usually performed without contrast 
followed by three contrasted series of images in the 
arterial, venous, and delayed phases to assist in localizing 
the bleed. A positive study occurs when there is contrast 
extravasation into the bowel lumen or identification of 
an abnormal vessel, mass, or other underlying etiology; 
the same is true for conventional catheter based angio­
graphy[8,25]. CT angiography can detect bleeds with a 
reported sensitivity of 0.5 cc/min of active extravasation 
which is compared to the sensitivity of catheter arterio­
graphy rate of detection of at least 1 cc/min[25]. 
Another imaging modality for patients is technetium 
labeled red blood cell scintigraphy. In this study, patient’s 
red blood cells are tagged with technetium and imaged 
for 60­90 min. Pooling of radiotracer is considered to be 
positive. Typical rates of bleeding required for detection of 
bleeding have been reported between 0.05­0.5 cc/min[25]. 
A benefit of this study is the ability to detect arterial or 
venous bleeding; a disadvantage, in turn, becomes the 
lack of precisely identifying the location of the bleed. 
Sensitivity and specificity of this study are 91% and 95% 
Figure 1  Endoscopic image showing a large ulcer in the superior wall 
of the bulb with a large visible vessel. Attempted endoclip placement after 
epinephrine injection resulted in major bleeding and a loss of endoscopic view 
and patient was then emergently transferred to interventional radiology.
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respectively and are improved with increasing volume of 
extravasation[25].
As mentioned earlier, if endoscopy is unsuccessful 
at either identifying or stopping the bleeding source, 
transcatheter arteriography is the next step at inter­
vention. Typically, the femoral artery is used as the 
site for arterial access unless other factors prevent this 
approach; however, radial approach is an alternative 
which has been gaining interest at some centers[26]. 
If upper GI bleeding is suspected, the celiac artery is 
usually cannulated first[8]. Superselective evaluations 
are performed based on any prior studies used to help 
localize the location of the bleed. If a culprit vessel is 
identified, multiple methods of embolization have been 
described[8,27]. Patient breathing causes motion which can 
make visualization of bleeding difficult on angiography. 
Also, bowel gas and bowel movement can cause further 
limitations during catheter angiography.
There are many different techniques for embolization 
and controlling active hemorrhage. These include placing 
covered stents, endovascular coils/plugs, and embolic glue. 
In some instances, the microcatheter used to evaluate 
the culprit vessel will occlude and stop the hemorrhage 
temporarily. This can be utilized in temporary situations 
to spasm an artery to achieve hemostasis without per­
manently occluding an artery. Care must be taken to 
evaluate the vasculature in the region of bleeding as 
many sites in the GI tract have collateral blood flow. In 
sites that have collateral flow, a sandwich technique can 
be utilized; this requires identifying the bleeding site 
and embolizing the distal and proximal side branches to 
provide occlusion ensuring no distal reconstitution and 
decreasing chances of re­bleeding[8].
In some instances, patients are too hemodynamically 
unstable to obtain imaging and may need to go directly 
to the angiography suite or the endoscopy lab. Close 
communication between the emergency room physicians, 
anesthesiologists, surgeons, gastroenterologists, and 
interventional radiologists must be encouraged in order 
to provide optimal care for these critically ill patients. 
One important caveat to consider regarding angiography 
over endoscopy as a first line intervention is that angio-
graphy will only be positive if there is active bleeding, an 
abnormal vessel, or tumor blush. Also, active bleeding 
with high clinical suspicion of the approximate location 
of a bleed can be an appropriate indication of taking 
the patient directly to angiography in order to identify 
and treat the site of bleeding as active bleeding may 
terminate during the time taken to obtain imaging[28]. 
Hyperemia can be identified by angiography but subtle 
A B
Figure 2  During interventional angiography, selected fluoroscopic images showing a pseudoaneurysm of the gastroduodenal artery (A, red arrow) that 
was successfully coiled with subsequent hemostasis via the sandwich technique (B). Previously placed Endoclip is visible and can act as a fluoroscopic marker 
during angiography. 
A B
Figure 3  Fluoroscopic images of a case of 2-3 cm bleeding duodenal ulcer that failed endoscopic hemostasis with Endoclip application. A: Fluoroscopic 
image following contrast injection to the right gastric artery showing active extravasation into the lumen. The bleeding vessel (red arrow) is identified which is near the 
endoscopically placed clip; B: Digital subtraction angiography post coiling of the right gastric artery (green arrow). 
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mucosal abnormalities will be more readily identified 
with endoscopic management. Additionally, in cases 
of high risk ulcers which have had either successful or 
unsuccessful endoscopy, catheter arteriography has 
been shown to play a key role in preventing rebleeding 
by performing prophylactic embolization[29]. Surgical 
consultation is always recommended and performed at 
our hospital.
aCUTe lOweR GI bleeDING
Acute lower gastrointestinal bleeding is defined as bleed-
ing of recent duration (< 3 d), hemodynamic instability, 
anemia or requirement of blood transfusion[30]. Though 
most lower GI bleeds resolve spontaneously, mortality 
and morbidity is increased in elderly patients and those 
with comorbid medical conditions[31]. Bleeding rate and 
total blood loss become a critical factor in determin­
ing correct patient management. Initial management 
and assessment is similar to upper GI bleeds. A multi­
disciplinary approach is crucial for providing the best care 
for these critically ill patients.
Lower GI bleeding accounts for approximately 30% of 
all GI hemorrhage and has many etiologies[32]. The most 
common causes of lower GI bleeding are diverticula, 
angiodysplasia, anorectal neoplasm, and colitis[32,33]. 
The incidence increases with age with mean age of 
presentation ranging from 63 to 77 years of age. It has 
been estimated that lower GI bleeding is 200 times 
more likely in an 80 years old than a 20 years old[32]. 
Although bleeding can be life threatening, unlike upper 
GI bleeding, most cases of lower bleeding tend to be 
self­limited. Of the cases considered a lower bleed, the 
colon is the source in approximately 80% of cases[28]. 
Many patients with bleeding associated with diverticulosis 
can stop spontaneously in up to 80% of patients[32,33]. 
Mortality rates have been reported at less than 5%[34]. 
Initial management includes determination of the need 
for urgent evaluation and resuscitation with crystalloids 
and blood products and correction of coagulation factors 
in applicable. If stable, imaging plays a key role in 
identifying the source and etiology of the bleeding. 
As stated previously, CT and tagged red blood cell 
scintigraphy are excellent non­invasive options to assist 
with acute management decisions (Figures 4 and 5). 
Other useful tools in the management of patients with 
small bowel bleeding distal to the ligament of Treitz 
include capsule endoscopy and CT enterography to 
evaluate for a specific lesion or site of bleeding. Though 
diagnostic testing helps to localize the lesion, studies 
have shown that the diagnostic yield of colonoscopy 
ranges from 45% to 100%[34] which is higher than radio­
logical evaluation. If stable enough, patients should 
undergo urgent colonoscopy within 8 to 24 h of admission 
as that improves diagnostic yield and likelihood of 
therapeutic intervention. This was also demonstrated 
by Strate and Syngal[35] in 2003 where they studied 
144 patients and concluded that endoscopic therapy 
was successful in 29% of colonoscopies performed 
within 12 h and this dropped to 4% when performed 
between 24 to 48 h. These patients need to undergo 
rapid purge prep which involves drinking 1L of Golytely 
every 30 to 45 min until no fecal matter is noted in the 
effluent[36]. However, performing a colonoscopy at the 
time of active significant bleeding is often not useful as 
the bleeding impairs visualization in the colon; this is in 
contrast to angiography, which usually requires active 
extravasation to detect the hemorrhage. The various 
hemostatic devices are similar to the one discussed in 
the upper GI bleeding section. In cases of intermittent 
scant hematochezia, if hemodynamically stable, healthy 
individual less than 40 years of age can be considered for 
flexible sigmoidoscopy[37]. 
Diverticular bleeding accounts for 20% to 65% of 
acute lower GI bleeds[32] and causes significant bleeding 
in 3% to 15%[38] of the cases (Figure 6). The bleeding 
is characterized as painless hematochezia which stops 
simultaneously in 75% to 80% of the cases but recurs in 
about 25% to 40% of the cases within 4 years[38]. Endo­
scopic management involves using clipping or thermal 
Figure 4  A male patient presented with massive bright red blood per 
rectum which was unresponsive to transfusions. A representative computed 
tomography scan image demonstrates active contrast extravasation in the 
rectum (white arrow).
Figure 5  During interventional angiography, contrast extravasation is 
visualized into the colon via a distal branch artery from the internal iliac 
artery (white arrow). The culprit vessel was occluded by spasm or dissection at 
the ostium with no residual active bleeding. During follow-up lower endoscopy, 
an endoscopic image showed no active bleeding with discrete large sized clean 
based ulcers, consistent with ischemic colitis.
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contact modalities either alone or in conjugation with 
injection technique. Due to thinner walls of the right 
sided colon, perforation is a concern. Endoclip placement 
is often preferred to treat the bleeding or visible vessel 
at the neck or bottom of the diverticulum. If thermal 
methods are used care should be taken to apply lower 
setting for short periods of time only. Typically 10-15 
joules (heater probe) or 10 to 16 watts (bipolar) should 
be applied for 2 to 3 second pulse contacts and mild 
pressure[39,40]. Endoscopic clips can be either deployed 
over the bleeding vessel or use to oppose the walls to 
act as a tamponade effect and prevent bleeding[41]. 
Kaltenbach et al[42] described using EndoCap to evert the 
diverticulum and placing the clip. 
Ischemic colitis affects about 1% to 19% of the 
cases[35] and typically presents as painful hematochezia[43] 
affecting the water shed areas of the colon: Splenic 
flexure and rectosigmoid junction. The majority of patients 
respond to conservative management and treatment of 
the underlying condition. Angiography is recommended in 
patients with severe ischemic colitis, right sided colitis or 
suspicion of underlying thromboembolism or concurrent 
mesenteric ischemia[44]. Radiation proctitis is caused by 
radiation induced endarteritis obliterans with resultant 
telangiectasia and neovascularization in the rectum[45]. 
Effective treatment includes serial management with 
APC. 
The other etiologies for colitis such as Clostridium 
difficile colitis, inflammatory bowel disease, viral, bacterial 
and parasitic infections, diversion colitis can also present 
with hematochezia and usually managed by treating the 
underlying conditions. 
Angioectasias account for 3% to 15% of cases with 
lower GI bleeding[30], and their incidence also increase with 
age[46]. They range from 2 mm to several centimeters and 
are characterized by ectatic blood vessels radiating from 
a central feeding vessel[46]. Though both contact and non-
contact thermal methods are used for its treatment, APC 
is the preferred treatment modality[47]. Owing to thin walls 
of the right side of the colon power settings of 15 W to 
30 W at 1 L/min argon flow rate is utilized. Short pulses 
of 1 to 2 s are applied and the probe is held 1 to 3 mm 
away from the mucosa[40]. Lee et al[48] in 2010 described 
application of Hemoclips in conjugation with APC to 
control bleeding. 
Hemorrhoids are present in 75% of colonoscopies[46] 
but are indicated in only 2% to 10% of acute lower GI 
bleeds[49]. Bleeding hemorrhoids are usually managed 
with banding devices. Like esophageal varices they are 
also conducted in series with no more than 3 bands 
placed in one setting. 
Management of rectal ulcers and Dieulafoy’s lesion 
are similar to upper GI bleeds and achieved by thermal 
or mechanical methods or dual therapy, including in­
jection technique. Hence, as stated above most cases 
of lower GI bleeding are self­limited, but occasionally 
patients may present with massive GI bleeding where 
they are too unstable to undergo colonoscopy or despite 
drinking the prep the colon is still filled with blood 
obscuring endoscopic evaluation. In such cases, it is IR 
that can prove invaluable. Surgery is typically reserved as 
a last resort since even with location identified mortality 
is high, and mortality increases when the bleed cannot 
be localized. 
Angiography is similar regarding lower GI bleeds 
compared to upper bleeds. A major advantage compared 
to colonoscopy is that no bowel prep is needed. Typically, 
the interventional radiologist will begin with the superior 
mesenteric artery (SMA) as this will be the major supply 
to the distal small bowel, ascending and transverse 
colon. The inferior mesenteric artery (IMA) supplies the 
descending sigmoid colon as well as the rectum and 
anus. Branches of the internal iliac artery also supply 
the rectosigmoid colon and anus and become the main 
supply in cases of an occluded or diminutive IMA. Many 
collaterals and normal anatomic variants exist which 
must be evaluated prior to any interventions[28]. For 
instance, the SMA may provide arterial supply to the 
entire colon in the event the IMA is occluded via the arc 
of Riolan or marginal artery of Drummond which are 
arterio­arterio anastomoses between the superior and 
inferior mesenteric arteries[50].
Ideally, a selective embolization is performed if the 
etiology is discovered by angiography. When distal 
A B C
Figure 6  Fluoroscopic images of a case of colon diverticular bleeding that failed endoscopic hemostasis with Endoclip application. A: Active extravasation 
at the site of the clip (red arrow); B: Ongoing extravasation superior to the clip after initial coils placed in the inferior branch of the middle colic artery; C: Digital 
subtraction angiography following additional coils with no extravasation.
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branches are able to be cannulated, the risk of developing 
colonic ischemia is low and perhaps subclinical. Other 
methods such as vasospasm can prove useful to main­
tain normal blood flow while clot and hemostasis develop 
as demonstrated in Figures 4 and 5. 
GaSTROSTOMY TUbe
Though feeding tubes have been in place for over 400 
years it was not until 1980 that the first description of 
percutaneous endoscopic gastrostomy tube was atte­
mpted by Gauderer et al[51]. Subsequently, in 1981 the 
first percutaneous gastrostomy tube was placed under 
radiological guidance[52]. This was initially developed 
for cases where endoscopy could not be performed or 
was too risky to be attempted[52,53]. Since then, these 
two approaches have widely replaced surgical open 
gastrostomy owing to its minimally invasive nature, 
reduced cost and ease of tube placement[54]. These 
tubes are not only used for feeding but can also be used 
for decompression. Typical indications for gastrostomy 
tube are for providing nutrition in patients with an in­
ability to obtain adequate nutrition but with intact and 
functional GI tract. Impaired swallowing mechanism 
associated with neurological conditions and neoplastic 
conditions of the oropharynx, larynx and esophagus 
are some of the common indications[55,56]. It can also be 
performed to attain gastric decompression in patients 
with gastroparesis or obstruction such as peritoneal 
carcinomatosis. 
Absolute contraindications to this procedure are an 
uncorrectable coagulopathy, thrombocytopenia, peritonitis, 
or bowel ischemia. Large gastric varices, if known, can 
pose an increased risk of internal hemorrhage. Ascites 
or peritoneal dialysis is a relative contraindication given 
potential for pericatheter leakage and life threatening 
peritonitis respectively. In these patients, paracentesis 
can provide assistance to make the procedure safe[57]. 
In peritoneal dialysis patients, the procedure should be 
discussed with patient’s nephrologist. Contraindications 
specific for endoscopic placement include inability to 
bring the gastric wall in apposition with the anterior 
abdominal wall, facial fractures, skull fractures and upper 
GI obstruction[58]. In these cases, radiologically placed 
gastrostomy tube is preferred. Specific contraindications 
to radiologically placed feeding tubes include inability to 
travel to the radiology suite in patients with hemodynamic 
instability[58]. Also, prior gastric surgery can make the 
anatomical window smaller and more challenging sug­
gesting the need for CT guidance[55,56]. 
For percutaneous endoscopic gastrostomy tube 
placement, there are currently three techniques: (1) 
“pull” or Pomsky­Gauderer technique[51]: This involves 
insufflating the stomach and selecting an appropriate 
site by indenting the abdominal wall with a finger. 
Sterile precautions should then be followed and the site 
anesthetized with lidocaine. Subsequently the needle is 
advanced in to the stomach while withdrawing the plunger. 
The endoscopist confirms that the gastric puncture of 
the needle corresponds to the air in the syringe. This is 
essential to ensure the absence of any intervening bowel. 
A small skin incision is made and trocar is introduced into 
the stomach. A guidewire is then fed through the trocar 
and grasped endoscopically and pulled out through the 
mouth along with the endoscope. The feeding tube is 
then attached to the guidewire and pulled through the 
esophagus, stomach and abdominal wall and held in 
place by both internal and external bumper; (2) “push” or 
Sacks­vine technique[59]. This technique is similar to pull 
technique till the guidewire is placed. Then an introducer 
tube is threaded over the guidewire and pushed till it 
emerges through the abdominal wall and then is grasped 
manually and secured in position; and (3) introducer 
technique or Russell technique[60], this was developed 
in 1984 and has recently gained popularity to be used 
in cases with head and neck cancer to avoid seeding of 
the gastrostomy tract[61]. This uses a transabdominal 
approach. In this technique once the access to stomach 
is obtained endoscopically, gastropexy is performed next 
using either T fasteners[62] or gastropexy sutures[63]. 
Subsequently, the stomach is accessed with a needle 
and a guidewire. The tract is then dilated with a dilating 
catheter and finally a balloon tip gastrostomy catheter is 
placed into the stomach through the peel away sheath. 
Interventional radiological gastrostomy tube can 
be placed with either fluoroscopic, CT, or ultrasound 
guidance. These procedures can be performed with 
excellent success rates[55]. Success typically depends on 
the appropriate anatomic window in order to make a 
percutaneous approach into the stomach. Previous cross 
sectional imaging is utilized to evaluate for appropriate 
anatomical window for gastrostomy tube placement. 
Patients are administered barium orally or via nasogastric/
orogastric tube at least 12 h prior to the procedure in 
order to opacify the transverse colon. Upon the patient 
entering the IR suite, a nasogastric tube is inserted if not 
already present. At our institution, we then use ultrasound 
to evaluate the liver margin and outline prior to the 
procedure. The insertion site is chosen below the costal 
margin, above the transverse colon, and to the left of 
midline. Some institutions, including ours, will administer 
0.5­1 mg of intravenous glucagon to inhibit gastric motility 
during the procedure. The stomach is then insufflated with 
air. Gastropexy is next performed with T-fasteners in order 
to apply the stomach to the abdominal wall. An incision is 
then made between the gastropexy sutures. A needle is 
inserted into the stomach which is confirmed by aspirating 
air at an angle directed towards the pylorus. Care must 
be taken during these next steps to ensure the stomach 
remains insufflated with air; typically, a technologist 
will assist with insufflating air as needed. A wire is then 
inserted and the tract is dilated to the appropriate tube 
size. The gastrostomy tube is then inserted by using a 
peel­away sheath. Gastrostomy tubes may have a pigtail 
or balloon to secure within the stomach; we use tubes 
with balloons for securing the tube location. Contrast is 
then injected and both AP and lateral fluoroscopic views 
obtained to ensure the tube has been placed into the 
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stomach only and is secured to the abdominal wall. This 
procedure is illustrated in Figure 7. Occasionally, this 
method will be adjusted and performed under CT guidance 
for patients with a narrow anatomic window. Percutaneous 
sonographic gastrostomy which was initially described 
by Gebel et al[64] in 1991 for patients with upper GI tract 
obstruction is yet another technique. This procedure is 
currently not widely performed in United States, though is 
still popular in Europe. This process involves passage of a 
nasogastric tube into the stomach, followed by instillation 
500 to 1500 cc of water. The stomach is then localized by 
ultrasound. The puncture site into the stomach is identified 
after establishing absence of vessels and colon or small 
intestine interposition with ultrasound and Doppler. A small 
skin incision is made, and a needle is introduced into the 
stomach. A wire is then passed through the stomach into 
the duodenum. The puncture site is then dilated with 
serial dilators and gastrostomy tube placed. In 1998 Bleck 
et al[65], reported successful placement of feeding tube in 
38 patients via this method with no major complications 
reported in a 4 mo follow-up period. Major complications 
can include internal hemorrhage, catheter dislodgement, 
peritonitis/sepsis, or death. Minor complications are 
catheter leakage and clogging requiring exchange.
Thus, though studies have proven them to have equal 
success rates with both endoscopic and radiological tube 
placement, each procedure has a distinct advantage over 
the other[66]. With endoscopic placement, the procedure 
can be performed at the bed side and have diagnostic 
capabilities. In a study published in 1990, 10%­71% 
of patients were found to have abnormal endoscopy 
findings out of which management had to be altered 
in 36% of patients[67]. Also the endoscopic procedure 
reduces the radiation exposure. Meanwhile, radiological 
placement is possible in patients who fail endoscopic 
management such as those who are morbidly obese or 
have severe upper GI luminal narrowing[68]. Hence it is of 
utmost importance that practitioners are aware of these 
indications so that the patient can be sent to appropriate 
discipline for gastrostomy tube placement. 
CeCOSTOMY TUbeS
Cecostomy tubes can be placed surgically or percu­
taneously with endoscopic or image guidance[69]. These 
tubes are mainly indicated in patients with neurological 
disorder with resultant fecal incontinence to facilitate 
cleansing enemas[70], in the assistance of bowel training 
in the pediatric population, neurogenic bowel due to any 
issue, chronic colonic pseudo obstruction and colonic 
obstruction[71]. The contraindications are similar to ga-
strostomy tube[72,73]. 
Placement of a percutaneous endoscopic cecostomy 
tube is similar to endoscopic percutaneous gastrostomy 
tube placement[74]. The night before the procedure 4 
liters of Golytely is administered to clean the colon. In 
patients with chronic constipation more prolonged prep 
may be needed[75]. The colonoscope is then advanced all 
the way to the cecum which is insufflated. An appropriate 
site is selected by finger indentation in the right lower 
A B
C D
Figure 7  Selected fluoroscopic images demonstrating fluoroscopically guided gastrostomy placement. A: Contrast seen throughout the transverse colon; B: 
The first T-tac (white arrow) is deployed following needle insertion into the gastric lumen; C: Two more T-tacs placed; D: Static lateral image of the gastrostomy tube 
against abdominal wall and not in the colon. The contrast is injected into the tube to demonstrate intraluminal placement.
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quadrant and transillumination is performed. The rest 
of the procedure is similar to percutaneous endoscopic 
gastrostomy tube placement via the “pull” technique. 
The cecum needs to be fixed to the abdominal wall with 
the help of a “fixation” device to prevent leakage of the 
fecal content[69]. 
IR can perform these procedures either under 
fluoroscopic or CT guidance. The bowel will be prepped 
prior to the procedure similar to endoscopic procedures. 
Similar to gastrostomy tubes, the colon is insufflated 
with air and glucagon administered to decrease bowel 
contractions. A needle is inserted, T-tacks used to 
secure the position of the cecum, a wire inserted with 
subsequent dilation, and a tube is then inserted. This 
has been reported as a safe procedure although not 
commonly performed at our institution[72]. Though only 
small case series have been described, the procedure is 
easily performed and has a good success rate. However, 
the complication rate has been reported to be as high as 
42% and includes wound infection, bleeding, perforation 
leading to peritonitis and buried bumper syndrome[76]. 
Buried bumper syndrome (BBS) which is a well­known 
complication of gastrostomy tube placement, occurs due 
to excessive outward traction on the tube. In 2011 Rao 
et al[77] described its occurrence in a patient who had 
undergone percutaneous endoscopic cecostomy tube 
placement about 1.5 years prior to the presentation. 
BBS usually presents with peristomal cellulitis owing 
to the presence of intraluminal stool. If the tract is 
immature, BBS can lead to fecal peritonitis and intra­
abdominal sepsis. Management involves antibiotics and 
removal of the tube. Cecostomy tubes should not be 
removed by external traction as it can lead to colonic 
laceration. Instead, the tube should be cut externally 
and removed endoscopically with the help of a snare. 
This complication can potentially be prevented with 
the usage of balloon tube or by avoiding excessive 
traction. In 2006, Uno[78], described the introducer 
technique to reduce the incidence of wound infection. 
In 2015, Duchalais et al[79] published a prospective 
trial to evaluate the efficacy of constipation in patients 
undergoing percutaneous endoscopic cecostomy tube 
placement and reported successful results in three 
quarters of the patient population. However, chronic 
wound pain prompted the removal in the other one 
fourth of the patient population. Currently there are no 
trials comparing the efficacy of endoscopic and fluoro-
scopically placed percutaneous cecostomy tubes. 
STRICTUReS
Esophageal strictures are routinely seen in practice. The 
common causes include peptic strictures which develop as 
a sequel to GERD and account for almost 80% of benign 
strictures[80]. Their incidence seems to be decreasing in 
recent years with the more widespread use of proton 
pump inhibitors. Other causes include: Schatzki’s ring, 
radiation, caustic injury, anastomotic stricture, pill induced 
esophagitis, esophageal web, eosinophilic esophagitis 
and malignancy[81]. They can be further divided into 
simple and complex strictures[82]. Simple strictures 
are symmetric, < 2 cm in length, with a diameter of 
greater than equal to 12 mm, and allow easy passage 
of an upper endoscope. Complex strictures, however, 
are asymmetric, have a diameter < 12 mm, more than 
> 2 cm long, and do not allow the passage of the scope. 
Most of these strictures are amenable to treatment with 
dilation and stent placement which can be done both 
endoscopically and radiographically.
These patients present with dysphagia and should 
undergo initial endoscopic evaluation as that not only 
helps in diagnosis but can also aid in performing possible 
therapeutic intervention such as dilation[83]. Further, 
they can also assess to see if they are any predisposing 
factors such as angulated stricture, diverticula, and hiatal 
hernia which may increase the risk of complications. Most 
benign strictures respond to dilation unlike malignant 
strictures which have a greater risk of complications[84]. 
Active esophageal perforation is an absolute con­
traindication to dilation[85]. There are currently three 
types of dilators: Maloney bougie (without a guidewire), 
savory­Gilliard (passed over a guidewire) and through 
the scope (TTS) balloon dilators[86]. Prior to dilation, the 
endoscopist should consider the method of dilation, the 
diameter to which the obstruction should be dilated, need 
for wire guidance and need for radiographic screening[85]. 
Benign esophageal strictures are usually dilated to about 
13 to 15 mm. However Schatzki’s ring can be dilated 
to about 16 to 20 mm[85]. Maloney dilators range from 
16F to 60F and exert both longitudinal and radial force. 
This can be done blindly or under fluoroscopic guidance. 
These dilators can also be used for self-dilation without 
sedation[82]. Patients with benign esophageal stricture 
requiring frequent dilations are ideal candidates for 
self-dilation. The Maloney dilator is usually marked 
at two points: 20 cm from the entry site and 10 cm 
beyond the distal end of the stricture. The procedure is 
performed with the patient in sitting position. The dilator 
is lubricated with water and introduced over the tongue 
into the oropharynx. Once the patient visualizes the 20 
cm marking, the tube is in the esophagus. The dilator is 
then advanced until the second marking is seen at the 
level of incisors, which confirms the passage of maximal 
diameter of the dilator across the stricture. Lastly, the 
dilator is carefully withdrawn.
Similarly, Savory dilators also range from 16F to 
60F and have the same mechanism of action. The rigid 
tip is passed over a guidewire. They are also marked 
with radiopaque band at their maximal diameter. The 
guidewire is usually passed to the antrum and can be 
done endoscopically or fluoroscopically. Subsequently, 
the dilator is passed over the guidewire till the ma­
ximal diameter is beyond the stricture. If no force is 
experienced, then the dilator is slowly removed in one to 
one exchange manner to ensure the positioning of the 
guidewire. This uses tactile perception to determine the 
amount of resistance encountered. Sequential dilation 
is performed but usually in one setting no greater than 
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3 dilators are passed though studies have shown no 
increased risks with passing > 3 dilators in cases of a 
benign simple esophageal stricture[87]. TTS balloons work 
by exerting only radial force. They can usually increase 
up to 3 diameters and are useful for serial dilations with 
a single balloon. The endoscope is usually positioned 
proximal to the stricture and the balloon dilator is 
advanced through the stricture. The balloon is then 
inflated under direct endoscopic visualization and the 
pressure is held for 30 to 60 s. 
Studies have shown similar efficacy in treating peptic 
strictures via any of the above mentioned methods[88,89]. 
In the treatment of postesophagectomy anastomotic 
strictures these methods show a similar efficacy of 
93%; however, they have a high recurrence rate and 
need multiple sessions[90,91]. Though most procedures 
are performed under endoscopic guidance, fluoroscopy 
is important in the setting of complex strictures as it 
aids in dilation[85]. Further in cases where an endoscope 
is unable to cross proximal lesions, fluoroscopic dilation 
must be performed. 
Fluoroscopic or other image guided balloon dilatation 
has been described in the literature as a safe method for 
stricture treatment of the esophagus in various disease 
states[92,93]. However, this has not been a common 
procedure in our IR department. In cases of refractory 
benign strictures, steroid injection into the stricture prior 
to dilation has shown to be effective in increasing post 
dilation diameter, reducing the need for repeat dilation 
and increasing the interval between dilations. Temporary 
esophageal stenting is also an option. A systemic review 
published regarding the use of plastic stents in benign 
esophageal strictures reported successful dilation in 52% 
of the cases. However, stent migration was reported in 
24% of the population[94]. Song et al[95] in 2000 published 
a study where fully covered metal stents were placed in 
25 patients, but migration was noted in 80% while 48% 
of them developed a new stricture. Few studies[96,97] have 
also been published regarding the use of biodegradable 
stents without promising results. 
Similar to the upper GI tract, patients with inflam­
matory bowel disease are known to develop strictures. 
This is more common in Crohn’s disease where 40% of 
patients with ileal disease develop strictures[98]. Further 
studies demonstrate that 60% of patients with strictures 
would undergo surgery within the next 20 years[99]. 
Strictures in Crohn’s disease can occur de novo, at the site 
of bowel anastomosis, or at the ileal pouch. They can be 
divided into inflammatory vs fibrotic[100]. Inflammatory 
strictures can be treated with medical management. 
However, fibrotic strictures were traditionally treated 
with only surgical management[101]. Studies have shown 
that stricturoplasty tends to preserve bowel length 
and is associated with high recurrence rate leading to 
frequent operations. In younger adults, the course tends 
to be more aggressive leading to frequent operations 
and finally short bowel syndrome[102]. Endoscopic 
managements have been devised in an attempt to 
reduce this dreaded complication. Prior to any therapy 
endoscopic evaluation and biopsy, assessment of the 
stricture must be performed to rule out malignancy 
especially in the setting of ulcerative colitis. Endoscopic 
management includes dilation therapy, local injection 
of steroids, needle­knife stricturotomy and stent 
placement[103]. The technique of balloon dilation (TTS) 
is similar to the one described for esophageal stricture. 
Endoscopic balloon dilation has shown to both avoid or 
delay the need for surgery, though frequent dilations 
may be needed. In a systemic review published by 
Hassan et al[104] in patients with Crohn’s disease related 
strictures, endoscopic dilation achieved success in 86% 
of the patients with long term clinical efficacy obtained 
in 56% of them. In a multivariate analysis, stricture 
length of < 4 cm was the only predictor for surgery free 
follow up period. The mean adverse events (perforation 
and bleeding) were less than 2%. In 2010, Mueller et 
al[105] published a prospective single center study of 55 
patients. They reported an initial success rate of 95% 
with 76% of those patients not requiring surgery during 
the follow­up period. Given the high relapsing rate, 
addition of steroid injection to the stricture at the time 
of dilation has been studied. However, currently the 
data is conflicting[106,107]. More recently stent placement 
at the time of endoscopy in this patient population has 
been evaluated. However, studies using self­expandable 
metallic stents (SEMS)[108] and biodegradable stents[109] 
have reported high rates of stent migration and other 
adverse events. In 2012 Loras et al[110] published a small 
series of 25 SEMS placement with technical success 
obtained in 92% of the stent placements that was 
maintained for a 4 wk follow-up period. 
Similar to upper GI strictures, fluoroscopic guided 
balloon dilatation and/or stent placement has also been 
described for the lower GI tract for patients as a pre­
surgical or palliative relief[111,112]. Typically, the procedure 
involves placing the patient supine on the fluoroscopy 
table. A wire is then inserted through the anus retrograde 
to the level of the obstruction. Once the wire passes 
the obstruction and is proximal, a catheter is inserted 
for the purpose of water soluble contrast injection. This 
step is critical to evaluate the dimensions of the stent 
and type of delivery system used. Appropriate stents 
should cover the lesion with 1­2 cm extension beyond 
the obstruction. Covered stents are not recommended 
due to risk of migration[111]. Water­soluble contrasted 
enema can be repeated immediately or any time after 
the procedure to evaluate placement. However, this is 
also another procedure not commonly performed in our 
IR department.
CONClUSION
Advances in the medical field have been to the advan­
tage of the patient in many disease processes as 
discussed above. In today’s era of minimally invasive 
procedures, surgery as a first choice of management 
is getting less popular. Therapeutic endoscopy and 
interventional radiology have come a long way from their 
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initial inception to being main modalities of treatment. 
Treatment modality of choice is often based on avail-
ability of the services, clinical stability of the patients 
and their presentation. However, these are complex 
patients that often require close collaboration between 
gastroenterologists, radiologists and surgeons. 
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